Migdal Insurance & Financial Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,660
Closed -$59K 481
2023
Q4
$59K Hold
2,660
﹤0.01% 325
2023
Q3
$49K Hold
2,660
﹤0.01% 318
2023
Q2
$67K Sell
2,660
-2,660
-50% -$66.9K ﹤0.01% 310
2023
Q1
$130K Buy
5,320
+2,660
+100% +$71.2K ﹤0.01% 293
2022
Q4
$63K Hold
2,660
﹤0.01% 299
2022
Q3
$70K Buy
2,660
+2,000
+303% +$70.2K ﹤0.01% 281
2022
Q2
$22K Hold
660
﹤0.01% 460
2022
Q1
$48K Sell
660
-110
-14% -$7.92K ﹤0.01% 443
2021
Q4
$73K Sell
770
-2,571
-77% -$307K ﹤0.01% 407
2021
Q3
$424K Buy
3,341
+324
+11% +$47.2K ﹤0.01% 254
2021
Q2
$502K Buy
3,017
+392
+15% +$63.5K 0.01% 271
2021
Q1
$477K Buy
+2,625
New +$609K ﹤0.01% 325

Other funds holding TDOC

Migdal Insurance & Financial Holdings's TDOC Position: Q1 2024 in Review

Migdal Insurance & Financial Holdings sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 2,660 shares — an estimated $59K sold.

Migdal Insurance & Financial Holdings first reported a position in TDOC in Q1 2021 and held it in 12 quarters. The position peaked at $502K in Q2 2021. 427 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Migdal Insurance & Financial Holdings reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 2,660 Teladoc Health shares in Q1 2024, an estimated $59K.
  • Migdal Insurance & Financial Holdings first reported a position in Teladoc Health in Q1 2021 and held it in 12 quarters.
  • Migdal Insurance & Financial Holdings's Teladoc Health position peaked at $502K in Q2 2021.
  • 427 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2024, filed 1 May 2024.